Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive rats

Peptides

Volumn 27, Issue 2, 2006, Pages 438-443

  Nordheim, Ulrich ^a   Nicholson, Janet R ^a   Dokladny, Karol ^a   Dunant, Patrick ^a   Hofbauer, Karl G ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Blood pressure; Body temperature; Food intake; Heart rate; Locomotor activity; Melanocortins; Sibutramine; Sympathetic nerve activity

Indexed keywords

ANOREXIGENIC AGENT; HP228; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 3 RECEPTOR AGONIST; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 4 RECEPTOR AGONIST; NORADRENALIN; SIBUTRAMINE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BODY TEMPERATURE; CARDIOVASCULAR EFFECT; DRUG MECHANISM; FEEDING BEHAVIOR; FOOD INTAKE; HEART RATE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TELEMETRY;

ANIMALS; BODY TEMPERATURE; CARDIOVASCULAR PHYSIOLOGY; CYCLOBUTANES; FEEDING BEHAVIOR; MALE; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELANOCORTIN, TYPE 4; TETRAHYDROISOQUINOLINES; TRIAZOLES; WAKEFULNESS;

ANIMALIA;

EID: 31544470058     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.01.026     Document Type: Article

References (25)

1. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
2. D.J. De Wildt, H. Krugers, C.M. Kasbergen, H. De Lang, and D.H.G. Versteeg The hemodynamic effects of 2-melanocyte-stimulating hormone and related melanotropins depend on the arousal potential of the rat Eur J Pharmacol 233 1993 157 164
3. J.C. Dunbar, and H. Lu Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions Peptides 21 2000 211 217
4. G. Eisenhofer, T. Saigusa, and M.D. Esler Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits Am J Physiol 260 1991 R824 R832
5. W. Fan, B.A. Boston, R.A. Kesterson, V.J. Hruby, and R.D. Cone Role of melanocortinergic neurons in feeding and the agouti obesity syndrome Nature 385 1997 165 168
6. H.L. Fehm, R. Smolnik, W. Kern, G.P. McGregor, U. Bickel, and J. Born The melanocortin melanocyte-stimulating hormone/adrenocorticotropin 4-10 decreases body fat in humans J Clin Endocrinol Metab 86 2001 1144 1148
7. S.Q. Giraudo, C.J. Billington, and A.S. Levine Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands Brain Res 809 1998 302 306
8. S.D. Glick, R.E. Haskew, I.M. Maisonneuve, J.N. Carlson, and T.P. Jerussi Enantioselective behavioral effects of sibutramine metabolites Eur J Pharmacol 397 2000 93 102
9. T. Gura Obesity drug pipeline not so fat Science 299 2003 849 852
10. J.E. Hall, E.D. Crook, D.W. Jones, M.R. Wofford, and P.M. Dubbert Mechanisms of obesity-associated cardiovascular and renal disease Am J Med Sci 324 2002 127 137
11. L.K. Heisler, M.A. Cowley, L.H. Tecott, W. Fan, M.J. Low, and J.L. Smart Activation of central melanocortin pathways by fenfluramine Science 297 2002 609 611
12. V.J. Hruby, S.D. Sharma, K. Toth, J.Y. Jaw, F. Al-Obeidi, and T.K. Sawyer Design, synthesis, and conformation of superpotent and prolonged acting melanotropins Ann NY Acad Sci 680 1993 51 63
13. D. Huszar, C.A. Lynch, V. Fairchild-Huntress, J.H. Dunmore, Q. Fang, and L.R. Berkemeier Targeted disruption of the melanocortin-4 receptor results in obesity in mice Cell 88 1997 131 141
14. K. Kramer, and L.B. Kinter Evaluation and applications of radiotelemetry in small laboratory animals Physiol. Genomics 13 2003 197 205
15. J.J. Kuo, A.A. da Silva, and J.E. Hall Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function Hypertension 41 2003 768 774
16. J.J. Kuo, A.A. da Silva, L.S. Tallam, and J.E. Hall Role of adrenergic activity in pressor responses to chronic melanocortin activation Hypertension 43 2004 370 375
17. B.E. Levin Reduced norepinephrine turnover in organs and brains of obesity-prone rats Am J Physiol 268 1995 R389 R394
18. S.J. Li, K. Varga, P. Archer, V.J. Hruby, S.D. Sharma, and R.A. Kesterson Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones J Neurosci 16 1996 5182 5188
19. C.A. Luque, and J.A. Rey Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity Ann Pharmacother 33 1999 968 978
20. S. MacMahon, R. Peto, J. Cutler, R. Collins, P. Sorlie, and J. Neaton Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 335 1990 765 774
21. K. Matsumura, T. Tsuchihashi, I. Abe, and M. Iida Central alpha-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits Brain Res 948 2002 145 148
22. R.S. Mazzeo, and P.A. Gantham Sympathetic response to exercise in various tissues with advancing age J Appl Physiol 66 1989 1506 1508
23. R.C. Rosen, L.E. Diamond, D.C. Earle, A.M. Shadiack, and P.B. Molinoff Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra Int J Impot Res 16 2004 135 142
24. I.K. Sebhat, W.J. Martin, Z. Ye, K. Barakat, R.T. Mosley, and D.B. Johnston Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium-3- ylcarbonyl]-(1R)-1-(4-chlorobenzyl)-2-[4-cyclohexyl-4-(1H-1,2, 4-triazol-1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist J Med Chem 45 2002 4589 4593
25. T. Yasuda, T. Masaki, T. Kakuma, and H. Yoshimatsu Hypothalamic melanocortin system regulates sympathetic nerve activity in brown adipose tissue Exp Biol Med 229 2004 235 239